| 1 |
35446431 | Five-Year PTSD Symptom Remission in Two Patients Following Treatment With Rivastigmine. | 2022 Apr 21 |
1 |
| 2 |
35455397 | 5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study. | 2022 Mar 25 |
1 |
| 3 |
35563011 | The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer's Disease. | 2022 Apr 21 |
1 |
| 4 |
35595404 | Pharmacogenetic studies in Alzheimer disease. | 2022 May |
1 |
| 5 |
35624580 | Scalable Functionalization of Polyaniline-Grafted rGO Field-Effect Transistors for a Highly Sensitive Enzymatic Acetylcholine Biosensor. | 2022 Apr 27 |
1 |
| 6 |
34285627 | The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease. | 2021 |
1 |
| 7 |
34522196 | Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase. | 2021 Oct |
3 |
| 8 |
34547176 | Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment. | 2021 Nov |
3 |
| 9 |
34832918 | The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro. | 2021 Nov 9 |
4 |
| 10 |
34911424 | Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction. | 2021 |
2 |
| 11 |
31942651 | In Vitro and in Vivo Optimization of Phase Sensitive Smart Polymer for Controlled Delivery of Rivastigmine for Treatment of Alzheimer's Disease. | 2020 Jan 15 |
1 |
| 12 |
31978679 | Design, synthesis and evaluation of pyrazole bearing α-aminophosphonate derivatives as potential acetylcholinesterase inhibitors against Alzheimer's disease. | 2020 Mar |
1 |
| 13 |
32092302 | An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes. | 2020 Mar 1 |
1 |
| 14 |
32414155 | Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future? | 2020 May 13 |
1 |
| 15 |
32443670 | MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy. | 2020 May 20 |
4 |
| 16 |
32874532 | QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine. | 2020 |
1 |
| 17 |
33488178 | Combined ligand and structure-based virtual screening approaches for identification of novel AChE inhibitors. | 2020 |
1 |
| 18 |
30673880 | Advances in Management of Psychosis in Neurodegenerative Diseases. | 2019 Jan 23 |
1 |
| 19 |
30771282 | Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies. | 2019 May |
1 |
| 20 |
31162119 | [Lewy body dementia: therapeutic propositions according to evidence based medicine and practice]. | 2019 Jun 1 |
1 |
| 21 |
32995249 | Successful Resuscitation of a Young Girl Who Drank Rivastigmine With Respiratory Failure. | 2019 Dec 1 |
2 |
| 22 |
28060207 | Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study. | 2018 Jan/Feb |
1 |
| 23 |
28617100 | Discovery of potent and selective acetylcholinesterase (AChE) inhibitors: acacetin 7-O-methyl ether Mannich base derivatives synthesised from easy access natural product naringin. | 2018 Mar |
1 |
| 24 |
29527733 | Synthesis, biological evaluation, and docking studies of some 5-chloro-2(3H)-benzoxazolone Mannich bases derivatives as cholinesterase inhibitors. | 2018 Apr |
1 |
| 25 |
29777723 | Effect of acetylcholinesterase inhibitors donepezil and rivastigmine on the activity and expression of cyclooxygenases in a model of the inflammatory action of fluoride on macrophages obtained from THP-1 monocytes. | 2018 Aug 1 |
2 |
| 26 |
30343499 | Thiazole-substituted benzoylpiperazine derivatives as acetylcholinesterase inhibitors. | 2018 Dec |
1 |
| 27 |
30577562 | Influence of Acetylcholinesterase Inhibitors Used in Alzheimer's Disease Treatment on the Activity of Antioxidant Enzymes and the Concentration of Glutathione in THP-1 Macrophages under Fluoride-Induced Oxidative Stress. | 2018 Dec 20 |
3 |
| 28 |
28458525 | Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia. | 2017 |
4 |
| 29 |
28711758 | Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies. | 2017 Sep |
1 |
| 30 |
28827871 | Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia. | 2017 Apr-Jun |
1 |
| 31 |
30183230 | Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview. | 2017 Feb |
1 |
| 32 |
26795874 | Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. | 2016 Mar |
1 |
| 33 |
26947959 | Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. | 2016 Apr 1 |
1 |
| 34 |
27073702 | Acquired Localized Hypertrichosis Induced by Rivastigmine. | 2016 |
1 |
| 35 |
27597816 | Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration. | 2016 |
2 |
| 36 |
28635795 | [Current approaches to optimize treatment of dementia and Alzheimer's disease]. | 2016 |
1 |
| 37 |
25904872 | Musical hallucinations treated with acetylcholinesterase inhibitors. | 2015 |
1 |
| 38 |
26264921 | From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease. | 2015 |
2 |
| 39 |
26455564 | Possibility of Acetylcholinesterase Overexpression in Alzheimer Disease Patients after Therapy with Acetylcholinesterase Inhibitors. | 2015 |
1 |
| 40 |
26642212 | Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada. | 2015 |
1 |
| 41 |
26664715 | Cognitive Impairment and Electroconvulsive Therapy in Geriatric Depression, What Could be the Role of Rivastigmine? A Case Series. | 2015 Sep 28 |
1 |
| 42 |
24239594 | Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. | 2014 Apr 3 |
1 |
| 43 |
24504487 | Reduction of parkinsonism and psychosis with mirtazapine: a case report. | 2014 May |
1 |
| 44 |
24774720 | Rapid detoxification of benzodiazepine or Z-drugs dependence using acetylcholinesterase inhibitors. | 2014 Jul |
1 |
| 45 |
24797332 | Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice. | 2014 Jul 11 |
2 |
| 46 |
25082512 | Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer's disease therapy. | 2014 Sep 1 |
1 |
| 47 |
25202788 | [Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases]. | 2014 |
1 |
| 48 |
25205193 | Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B. | 2014 Oct 1 |
1 |
| 49 |
25260958 | Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors. | 2014 Nov 1 |
1 |
| 50 |
22391555 | Acetylcholinesterase capillary enzyme reactor for screening and characterization of selective inhibitors. | 2013 Jan 25 |
1 |